Asymmetry Capital Management, L.P. - AMICUS THERAPEUTICS INC ownership

AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 191 filers reported holding AMICUS THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 0.71 and the average weighting 0.3%.

Quarter-by-quarter ownership
Asymmetry Capital Management, L.P. ownership history of AMICUS THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$8,278,000
+32.6%
716,709
+9.6%
4.39%
+17.0%
Q3 2021$6,245,000
+116.5%
653,976
+118.5%
3.75%
+89.3%
Q2 2021$2,885,000
-18.5%
299,284
+27.5%
1.98%
-26.9%
Q2 2020$3,540,000
+20.4%
234,753
-26.2%
2.71%
-15.6%
Q1 2020$2,940,000
+205.6%
318,152
+222.3%
3.22%
+86.5%
Q4 2019$962,000
+3.2%
98,718
+1.5%
1.72%
-33.0%
Q4 2018$932,000
-78.5%
97,294
-72.8%
2.58%
-35.6%
Q3 2018$4,331,000
+109.8%
358,191
+171.0%
4.00%
+97.2%
Q2 2018$2,064,000
-29.5%
132,160
-32.1%
2.03%
-44.6%
Q1 2018$2,929,000
-4.6%
194,745
-8.7%
3.66%
-12.1%
Q4 2017$3,071,000
-4.4%
213,413
+0.2%
4.17%
+11.9%
Q3 2017$3,213,000
-20.6%
213,059
-47.0%
3.73%
-22.4%
Q2 2017$4,047,000
-10.6%
401,909
-36.7%
4.80%
-24.0%
Q1 2017$4,527,000
+20.4%
634,865
-16.1%
6.31%
-9.7%
Q4 2016$3,760,000
-17.8%
756,596
+22.4%
6.99%
-12.1%
Q3 2016$4,576,000
+264.9%
618,317
+169.3%
7.96%
+246.4%
Q2 2016$1,254,000
-55.5%
229,626
-31.1%
2.30%
-68.7%
Q1 2016$2,818,000
+48.9%
333,513
+70.9%
7.35%
+156.6%
Q4 2015$1,893,000
-41.9%
195,206
-16.2%
2.86%
-60.6%
Q3 2015$3,259,000232,9577.26%
Other shareholders
AMICUS THERAPEUTICS INC shareholders Q4 2017
NameSharesValueWeighting ↓
Redmile Group, LLC 22,792,634$284,452,0008.05%
Perceptive Advisors 21,509,486$268,438,0006.16%
SECTORAL ASSET MANAGEMENT INC 3,324,623$41,491,0004.96%
Palo Alto Investors LP 7,796,299$97,298,0004.73%
Avoro Capital Advisors LLC 10,000,000$124,800,0004.31%
SPHERA FUNDS MANAGEMENT LTD. 2,510,320$31,329,0004.29%
Novo Holdings A/S 2,317,870$28,927,0004.05%
Ghost Tree Capital, LLC 1,450,000$18,096,0003.75%
Copernicus Capital Management, LLC 325,000$4,056,0003.61%
Boxer Capital, LLC 2,325,000$29,016,0002.50%
View complete list of AMICUS THERAPEUTICS INC shareholders